Thematic

neurologylive.com

SKY-0515 Demonstrates Dose-Dependent Reductions in Mutant Huntingtin Protein in Phase 1 Update | NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Read the original →

What this article backs

• Sky 0515 ↓ Mutant Huntingtin Protein
• Sky 0515 Dose Level ↓ Mutant Huntingtin Protein

• Sky 0515 decreases Mutant Huntingtin Protein.
• Sky 0515 Dose Level decreases Mutant Huntingtin Protein.

In its own words

SKY-0515 Demonstrates Dose-Dependent Reductions in Mutant Huntingtin Protein in Phase 1 Update

Corroborated by

• Illustration E

  Skyhawk reports encouraging 12-month results for oral Huntington’s disease drug SKY-0515 – HDBuzz

  en.hdbuzz.net · Jun 1, 2026 Standard

  Backs 1 claim

  • Sky 0515 ↓ Mutant Huntingtin Protein

  Read article →